Form 8-K - Current report:
SEC Accession No. 0001279569-21-001638
Filing Date
2021-11-18
Accepted
2021-11-17 17:51:32
Documents
15
Period of Report
2021-11-17
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K form8k.htm   iXBRL 8-K 29776
2 NEWS RELEASE DATED NOVEMBER 17, 2021 ex991.htm EX-99.1 139825
3 GRAPHIC logo.jpg GRAPHIC 2466
  Complete submission text file 0001279569-21-001638.txt   398606

Data Files

Seq Description Document Type Size
4 EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA na-20211117.xsd EX-101.SCH 3559
5 EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE na-20211117_lab.xml EX-101.LAB 36074
6 EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE na-20211117_pre.xml EX-101.PRE 24867
7 XBRL DEFINITION FILE na-20211117_def.xml EX-101.DEF 26245
8 EXTRACTED XBRL INSTANCE DOCUMENT form8k_htm.xml XML 4296
Mailing Address 2900-550 BURRARD STREET VANCOUVER A1 V6C 0A3
Business Address 2900-550 BURRARD STREET VANCOUVER A1 V6C 0A3 (602) 682-7037
4Front Ventures Corp. (Filer) CIK: 0001783875 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56075 | Film No.: 211421757
SIC: 2833 Medicinal Chemicals & Botanical Products